Total Hip ArthroplastyANATHNCT06896591
Deep Posterior Post Gluteal Compartment Block in Total Hip Arthroplasty: Feasability and Safety
A study testing Deep posterior post gluteal nerve block in people with Total Hip Arthroplasty, run by Quincy Anesthésie.
Trial summary
This study aims to evaluate the effectiveness of a posterior hip capsule block performed in addition to a PENG (Pericapsular Nerve Group) block for patients undergoing hip arthroplasty. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Total Hip Arthroplasty
- What is being tested?
- Deep posterior post gluteal nerve block
- Type of treatment
- Injection or infusion, Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 35 participants
- Where
- No sites listed yet
- Study dates
- 1 Jun 2025to 1 Mar 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- All adults with total hip arthroplasty
- -
Who cannot join
- Contraindication to regional anesthesia
- allergy
- refusal of the injection
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Effets D'un Bloc Glutéal Postérieur Profond Associé À Un PENG Bloc Dans La Prothèse Totale De Hanche
This study aims to evaluate the effectiveness of a posterior hip capsule block performed in addition to a PENG (Pericapsular Nerve Group) block for patients undergoing hip arthroplasty. The primary objective is to assess whether this combined approach provides enhanced perioperative analgesia compared to the standard analgesic protocol or the PENG block alone. Secondary outcomes will focus on opioid consumption, functional recovery, and any potential complications. By targeting both the anterior and posterior innervation pathways around the hip joint, this combined technique could improve patient comfort, decrease opioid requirements, and potentially expedite rehabilitation after hip arthroplasty.
- Conditions
- Total Hip Arthroplasty
- Being tested
- Deep posterior post gluteal nerve block
- Keywords
- total hip arthroplasty, peng block, Hip, Anatomy, Sciatic nerve block
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Deep posterior post gluteal nerve blockProcedure or surgery
One injection with ultrasound guidance injection of 5, 10 or 15 mL of naropeine 0.35 % Procedure : injection below the piriformis muscle in front of the head of the femur.
| Study group | Role | What they receive |
|---|---|---|
| DPPG compartment block | Experimental | Deep posterior post gluteal compartment block with different volume of product 5,10 and 15 ml (local anesthetics such as naropeine 0.35%) to compare the efficiency of the block without sciatic nerve block effect Receives: Procedure: Deep posterior post gluteal nerve block |
What is being measured
The primary outcome is the main question the study is designed to answer.
Sciatic nerve block
number of patients with postoperative sciatic motor or sensitory nerve block collected by clinical examination (test with hot and cold in the sciatic territory and motricity of the feet)
Measured: From enrollment to the end of treatment at 1 month
Secondary outcomes (5)
Pain postoperative
Visual analogic pain (VAS) AT 6 hours 0 : no pain 10: maximum pain
Measured: From enrollment to the end of treatment at 1 MONTH
pain 2
Visual analogic pain (VAS) AT 12 hours 0 : no pain 10: maximum pain
Measured: From enrollment to the end of treatment at 1 MONTH
oPIOID Consumption
Opioid consumption per and postoperative until 48 hours
Measured: From enrollment to the end of treatment at 7 months
RAAC
QOR15 scale at H24 and H48 questionnaire with 15 questions from 0 to 10 (https://pqip.org.uk/FilesUploaded/Myles%20QoR-15.pdf)
Measured: From enrollment to the end of treatment at 1 MONTH
Surgical complication
Surgical postoperative complication or fall
Measured: From enrollment to the end of treatment at 1 MONTH
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Mar 2025
- Study start1 Jun 2025 (estimated)
- Primary completion1 Feb 2026 (estimated)
- Study completion1 Mar 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Total Hip ArthroplastyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 35 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Quincy Anesthésie
- Sponsor type
- Research network
- Responsible party
- Principal investigator, Yoann ELMALEH, Quincy Anesthésie
- Investigators
- yoann ELMALEH, M.D, Principal investigator, Hopital Privé Claude Galien
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06896591
- Sponsor's protocol ID
- COS-RGDS-2024-06-039-P-ELMALEH
- Acronym
- ANATH
- Status last verified
- Mar 2025
- First submitted
- 13 Mar 2025
- Last updated
- 26 Mar 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Pun M, Ng T, Vermeylen K, Tran J. Innervation of the hip joint: implications for regional anaesthesia and image-guided interventional pain procedures. BJA Educ. 2024 Jun;24(6):191-202. doi: 10.1016/j.bjae.2024.02.005. Epub 2024 Apr 8. No abstract available.
PubMed 38764441
Study at a glance
From the registry record, last updated by the sponsor on 26 Mar 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effets D'un Bloc Glutéal Postérieur Profond Associé À Un PENG Bloc Dans La Prothèse Totale De Hanche
- ClinicalTrials.gov ID
- NCT06896591
- Acronym / sponsor ID
- ANATH / COS-RGDS-2024-06-039-P-ELMALEH
- Conditions
- Total Hip Arthroplasty
- Keywords
- total hip arthroplasty, peng block, Hip, Anatomy, Sciatic nerve block
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 35 participants (estimated)
- Lead sponsor
- Quincy AnesthésieResearch network
- Study start
- 1 Jun 2025 (estimated)
- Primary completion
- 1 Feb 2026 (estimated)
- Study completion
- 1 Mar 2026 (estimated)
- First posted
- 26 Mar 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to evaluate the effectiveness of a posterior hip capsule block performed in addition to a PENG (Pericapsular Nerve Group) block for patients undergoing hip arthroplasty. The primary objective is to assess whether this combined approach provides enhanced perioperative analgesia compared to the standard analgesic protocol or the PENG block alone. Secondary outcomes will focus on opioid consumption, functional recovery, and any potential complications. By targeting both the anterior and posterior innervation pathways around the hip joint, this combined technique could improve patient comfort, decrease opioid requirements, and potentially expedite rehabilitation after hip arthroplasty.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| DPPG compartment block | Experimental | Procedure: Deep posterior post gluteal nerve blockDeep posterior post gluteal compartment block with different volume of product 5,10 and 15 ml (local anesthetics such as naropeine 0.35%) to compare the efficiency of the block without sciatic nerve block effect |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- All adults with total hip arthroplasty
- -
Key exclusion criteria (3 listed)
- Contraindication to regional anesthesia
- allergy
- refusal of the injection
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Deep posterior post gluteal nerve blockOne injection with ultrasound guidance injection of 5, 10 or 15 mL of naropeine 0.35 % Procedure : injection below the piriformis muscle in front of the head of the femur. | Procedure or surgery | DPPG compartment block |
Primary outcome
Sciatic nerve block
Time frame: From enrollment to the end of treatment at 1 month
number of patients with postoperative sciatic motor or sensitory nerve block collected by clinical examination (test with hot and cold in the sciatic territory and motricity of the feet)
5 secondary outcomes
Pain postoperative
Time frame: From enrollment to the end of treatment at 1 MONTH
pain 2
Time frame: From enrollment to the end of treatment at 1 MONTH
oPIOID Consumption
Time frame: From enrollment to the end of treatment at 7 months
RAAC
Time frame: From enrollment to the end of treatment at 1 MONTH
Surgical complication
Time frame: From enrollment to the end of treatment at 1 MONTH
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Mar 2025.
- Background: PubMed 38764441Pun M, Ng T, Vermeylen K, Tran J. Innervation of the hip joint: implications for regional anaesthesia and image-guided interventional pain procedures. BJA Educ. 2024 Jun;24(6):191-202. doi: 10.1016/j.bjae.2024.02.005. Epub 2024 Apr 8. No abstract available.
- Individual participant dataSharing planned: Undecided
Related trials for Total Hip Arthroplasty
Enrolling by invitationPhase 2
Efficacy of Intravenous Oxytocin to Speed Recovery After THA
Total Hip Arthroplasty
RecruitingObservational study
Multicenter Mpact DM France
Total Hip Arthroplasty, Survival, Prosthesis
Active, not recruitingObservational study
EBRA Study AMISTEM-C FR
Total Hip Arthroplasty
Not yet recruiting
Early Mobilization and Postoperative Complications in Hip Arthroplast
Arthroplasty, Replacement, Hip, Patient Education
Active, not recruiting
CLinical Evaluation of ANtiseptic Skin Preparation in Revision Total Joint Arthroplasty of the Hip and Knee
Revision Total Hip Arthroplasty (RTHA), Revision Total Knee Arthroplasty
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
yoann ELMALEH, M.D principal investigator
Hopital Privé Claude Galien
Questions about this trial
What is this clinical trial studying?
A study testing Deep posterior post gluteal nerve block in people with Total Hip Arthroplasty, run by Quincy Anesthésie.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 26 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact YOANN ELMALEH, M.D (+33781330431, Yoyo.elmaleh@hotmail.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Sciatic nerve block (time frame: From enrollment to the end of treatment at 1 month). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06896591, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Mar 2025; AzTrials last refreshed its copy on 26 Oct 2026.